MiR-21-5p was finally screened as one promising candidate to target FDX1 mRNA based on the miRDB prediction software (Figure 6D), and its expression was negatively correlated with the overall survival time in ccRCC (Figure 6E). This evidence concerns the gene FDX1 and nonpapillary renal cell carcinoma.